SS Innovations International Inc. (NASDAQ: SSII) is advancing its strategy to make robotic surgery more accessible worldwide by combining seasoned financial leadership with a robust surgeon training program. The company recently appointed Sarah M. Romano as chief financial officer, a move that brings over two decades of finance and capital markets expertise to the organization. Romano has raised more than $100 million through public and private financings, a critical skill as SS Innovations seeks to fund its U.S. FDA clearance efforts for the SSi Mantra robotic surgical system and expand its international footprint.
In parallel, the company is investing in physician education through its SS International Centre for Robotics Surgery, which recently graduated its first cardiac robotic training class. The program trained 33 healthcare professionals from seven countries, underscoring the company's commitment to ensuring that surgeons are proficient in using the SSi Mantra platform. This dual focus on leadership and training is part of a broader strategy to pair cutting-edge technology with the necessary human expertise to drive adoption.
The significance of these developments lies in the company's positioning within the competitive robotic surgery market. By strengthening its executive team and investing in training, SS Innovations is addressing two key barriers to adoption: capital requirements and surgeon proficiency. The appointment of Romano, with her extensive experience in raising capital, is likely to bolster investor confidence and provide the financial resources needed to navigate regulatory pathways and scale operations. Meanwhile, the training center's first graduating class demonstrates tangible progress in building a global community of surgeons skilled in using the SSi Mantra system, which could accelerate acceptance in new markets.
For a detailed look at the full article, visit https://ibn.fm/lTCqR.
SS Innovations International develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.
